Applied DNA Sciences Inc (APDN)

[mcsharkey]

Yesterday's close evidently (IMHO) algorithmic response to late S3 filing put out on EDGAR. From the filing, explanatory note written in legalese. So I can't make too much of it.

Does seem like we are dotting eyes more that printing out new shares.

Gotta head off to work. You all have a great weekend. Here's a Link
EXPLANATORY NOTE
Common stock, par value $0.0001 per share, Underlying Listed Warrants 3,215,590
On October 2, 2014, the registrant filed a registration statement on Form S-1 (File No. 333-199121 ) with the Securities and Exchange Commission (the “SEC”), which was declared effective by the SEC on November 14, 2014. The prospectus included in such registration statement was supplemented from time to time, with the most recent prospectus supplement (no. 8) filed on September 18, 2015. Such registration statement, as supplemented, is referred to herein as the “Prior Registration Statement”. The Prior Registration Statement was used by the registrant to offer shares of its common stock and certain of its warrants that are listed on The NASDAQ Capital Market (the “Listed Warrants”). This Post-Effective Amendment No.1 to Form S-1 on Form S-3 (“Post-Effective Amendment”) is being filed to convert the Prior Registration Statement into a registration statement on Form S-3. This Post-Effective Amendment contains an updated prospectus relating to the sale by certain selling security holders of common stock to be received upon the exercise of our warrants and shall be deemed to be a post-effective amendment of the Prior Registration Statement for such purpose. If securities previously registered under the Prior Registration Statement are offered and sold before the effective date of this registration statement, the amount of previously registered securities so sold will not be included in the prospectus hereunder.

The prospectus contained in this registration statement also relates to the sale of common stock to be received by certain selling security holders upon the exercise of our private placement warrants (the “Concurrent Warrants”) that were sold in a private placement on November 27, 2015.

In addition, the prospectus contained in this registration statement relates to certain selling security holders upon the exercise of our warrants (the “Agent Warrants”) that were received as compensation for acting as a placement agent and/or underwriter in various public offerings and private placements that closed and/or were entered into on (i) January 7, 2011 as described in the registrant’s Current Report on Form 8-K filed on January 13, 2011, (ii) July 15, 2011 as described in the registrant’s Current Report on Form 8-K filed on July 15, 2011, (iii) November 20, 2014 as described in the registrant’s prospectus dated November 18, 2014 (Registration No. 333-199121), (iv) April 1, 2015 as described in the registrant’s prospectus supplement dated March 27, 2015 (Registration No. 333-202432), (v) November 27, 2015 as described in the registrant’s prospectus supplement dated November 23, 2015 (Registration No. 333-202432) and (vi) November 7, 2016 as described in the registrant’s Current Report on Form 8-K filed on November 3, 2016.


The information contained in this prospectus is not complete and may be changed. The selling security holders named in this prospectus m